TECHNOLOGICAL TRANSFER
TECHNOLOGICAL TRANSFER
Embedded Files
In biomedical research, technology transfer is essential to transform scientific advances into real clinical solutions. Patents and other forms of intellectual property protection ensure that original creations - such as therapeutic compounds, biomarkers or experimental models - can be valued, shared and safely developed by industry. This bridge between science and society not only drives innovation and public-private collaboration, but also accelerates the delivery of effective therapies to the patients who need them most.
Evaluation of neuroactive compounds. Synaptec Development LLC (EEUU).
PI. Manuela G. López. UAM. 01-01-2018/31-12-2022.
Validation of biomarkers of inflammatory origin and oxidative stress in traumatic brain injury.
Fundación Mutua Madrileña. PI. Manuela G. López. 2016-2019.
Sponsorship Chair UAM/BIOIBÉRICA- CABICYC (Bioibérica Chair in Chronic Inflammation and Cytoprotection).
Deputy director: Manuela G. López . May 2012 - May 2016.
Patents
Patents
SULPHATED DISACCHARIDES FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR NEUROVASCULAR DISEASES
COMPOUNDS DERIVED FROM 3-ALKYLAMINO-1H-INDOLE ACRYLATE, AND THE USE THEREOF IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
SULPHATED DISACCHARIDES FOR THE TREATMENT OF NEUROPATHIC PAIN
2-IODO-7-((((2-(2-(5-METHOXY-1H-INDOL-3-YL)ETHYL)AMINO)METHYL)-1-ALKYL/ARYL-6,7,7A,8-TETRAHYDRO-3H-PYRROLO[2,1-J]QUINOLINE-3,9(5H)-DIONE DERIVATIVES AS ANTIOXIDANT, NRF2-INDUCING AND NICOTINIC MODULATORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
Page updated
Google Sites
Report abuse